Sign up USA
Proactive Investors - Run By Investors For Investors

AusCann Group to outline next medicinal cannabis steps in Australia

The halt will remain in place until Wednesday 9th August 2017
Plants
AusCann has already harvested its first medicinal cannabis crop

AusCann Group Holdings Ltd (ASX:AC8) is preparing to provide an update on its Australian operations, and the ASX has granted the company a trading halt to prepare an announcement.

AusCann recently completed its first harvest in Chile with over 300 kilograms of dried cannabis buds.

The buds were then sent to a certified manufacturing facility for processing into medicinal cannabis formulations.

READ: AusCann Group Holdings Ltd secures two licences

During the June 2017 quarter, the company raised A$12mln with strong support from investors.

The halt will remain in place until the opening of trade on Wednesday 9th August 2017, or earlier if an announcement is made to the market.

View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

Related Articles

woman at a microscope
September 04 2017
Lead product Lojuxta generated revenues of €5.75mln in the first-half
researcher using microscope
September 28 2017
A total of £6mln is expected to come via a share placing and up to a further £2mln through an open offer of stock to existing investors
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use